Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Use of Propellants in MDI Production

Posted on By

SOP for Use of Propellants in MDI Production

Propellant Handling Procedures in MDI Production

1) Purpose

The purpose of this SOP is to establish procedures for the safe handling and use of propellants in metered-dose inhaler (MDI) production to ensure operator safety, product quality, and compliance with regulatory requirements.

2) Scope

This SOP applies to all personnel involved in the handling and use of propellants within the MDI production facility, including production operators, chemical engineers, and safety officers.

3) Responsibilities

The responsibilities for this SOP include handling propellants safely, monitoring storage conditions, conducting risk assessments, and ensuring compliance with safety protocols. Specific roles include:
Production Operators: Handle and transfer propellants according to established procedures.
Chemical Engineers: Assess propellant compatibility and conduct risk assessments.
Safety Officers: Monitor safety protocols and provide training on propellant handling procedures.

See also  SOP for Analytical Method Development for MDIs

4) Procedure

4.1 Propellant Storage and Handling
4.1.1 Store propellants in designated areas under controlled temperature and humidity conditions.
4.1.2 Use appropriate PPE (Personal Protective Equipment) during propellant handling operations.
4.2 Propellant Transfer
4.2.1 Transfer propellants using approved equipment and methods to minimize exposure and risk.
4.2.2 Conduct transfer operations in well-ventilated areas with adequate containment measures.
4.3

Emergency Procedures
4.3.1 Establish emergency response procedures for propellant spills, leaks, or accidents.
4.3.2 Train personnel on emergency response protocols and evacuation procedures.
4.4 Documentation
4.4.1 Maintain records of propellant handling procedures, including safety inspections and incident reports.
4.4.2 Document training records for personnel involved in propellant handling activities.

See also  SOP for Documentation in MDI Production

5) Abbreviations, if any

MDI: Metered-Dose Inhaler
SOP: Standard Operating Procedure
PPE: Personal Protective Equipment

6) Documents, if any

Propellant handling protocols, safety data sheets (SDS) for propellants, risk assessment reports, and training records should be maintained.

7) Reference, if any

Refer to regulatory guidelines from agencies such as the FDA, EMA, and OSHA for propellant handling and safety requirements in pharmaceutical manufacturing.

8) SOP Version

Version 1.0

Metered-Dose Inhaler Tags:Analytical Method Development MDIs, Batch Manufacturing Record MDI, Calibration MDI Equipment, Cleaning Equipment MDIs, Color Consistency Testing MDI, Contamination Prevention MDI, Documentation MDI Manufacturing, Final Product Inspection MDI, Formulation Development MDI, In-process Testing Inhalers, Inhaler Manufacturing Procedures, Inhaler Quality Control SOP, Labeling MDI SOP, MDI Production SOPs, MDI Storage Conditions, Metered-Dose Inhaler SOP, Microbial Testing Inhalers, Packaging of MDIs Procedure, Particle Size Analysis MDIs, Preservative Efficacy MDIs, Process Optimization MDIs, Process Validation MDIs, Propellant Testing MDIs, Quality Testing MDIs, Raw Material Inspection MDIs, Solvents Use in MDI Production, Stability Testing MDIs, Sterility Maintenance MDI, Training Personnel MDI Production, Waste Disposal MDI Production

Post navigation

Previous Post: SOP for Pharmacovigilance Safety Database Upgrades
Next Post: SOP for Sample Collection for Quality Testing in Powders

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version